Inhaled combination therapies for pulmonary fibrosis

Proprietary dry-powder inhaled therapies for pulmonary fibrosis and interstitial lung disease, built on the SPRAYE™ platform.

Contact

For partnering or investor conversations, write to us and we will reply with a short overview and propose a call.